Articles related to Endocrinology, Diabetes, Metabolism

This recent $1.4 million verdict in a medical malpractice case against a nurse practitioner serves as a critical reminder of the complexities surrounding legal responsibility in healthcare. Learn more about how this could impact your practice and the supervision of nurse practitioners.

The updated prescribing guidelines for Wegovy (semaglutide) offer new maintenance dosing options for adults, reflecting recent research findings.

A recent Danish cohort study reveals that older adults (≥75 years) may experience a more pronounced LDL-C reduction with low- to moderate-intensity statins than their younger counterparts. This finding emphasizes the need to consider age when prescribing statin therapy.

The recent systematic review comparing obesity management drugs highlights semaglutide and phentermine/topiramate as the most effective in weight loss and waist circumference reduction at 12 months. Explore the full study to understand the comparative efficacy and safety of these medications in obesity treatment.

The potential shortage of Saxenda (liraglutide) through 2023 underscores the importance of monitoring the availability of this weight management drug. Physicians should be aware of this situation and consider alternative options if necessary.

Explore the study’s analysis, which also uncovers potential cardiovascular benefits associated with SGLT2i initiation among patients with gout and type 2 diabetes.